These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1591726)

  • 1. Antibody drug carrier for immunotherapy of superficial bladder cancer: ultrastructural studies.
    de Harven E; Fradet Y; Connolly JG; Hanna W; He S; Wang Y; Choi BC; McGroarty R; Bootsma G; Tilups A
    Cancer Res; 1992 Jun; 52(11):3131-7. PubMed ID: 1591726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
    Mizutani Y; Yoshida O; Bonavida B
    J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypically heterogeneous deletion of the ABH antigen from the transformed bladder urothelium. A scanning electron microscope study.
    De Harven E; He S; Hanna W; Bootsma G; Connolly JG
    J Submicrosc Cytol; 1987 Oct; 19(4):639-49. PubMed ID: 3430650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ultrastructure of the basic cell types of human transitional cell bladder cancer].
    Gaĭyrov AG
    Arkh Patol; 1981; 43(6):46-52. PubMed ID: 7271498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of random biopsies of healthy mucosa in superficial bladder tumor].
    Fernández Gómez JM; Rodríguez Martínez JJ; Escaf Barmadah S; Pérez García J; García J; Casasola Chamorro J
    Arch Esp Urol; 2000 Nov; 53(9):785-97. PubMed ID: 11196385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro produced human antibodies in the treatment of superficial bladder cancer.
    Corrado F; Pizza G; Casanova S; De Vinci C; Fini M; Severini G; Menniti D; Corrado G
    J Exp Pathol; 1987; 3(4):347-58. PubMed ID: 3454800
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on multiple mucosal biopsy in patients with bladder cancer. 1. Evaluation of the results of multiple mucosal biopsy in patients with bladder cancer and in vivo methylene blue staining].
    Igawa M
    Hinyokika Kiyo; 1986 Nov; 32(11):1617-31. PubMed ID: 2435127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scanning electron microscopy of immuno-gold labeled antigens associated with bladder cancer.
    de Harven E; Connolly JG; Wang Y; Hanna W; Bootsma G
    Scanning Microsc; 1990 Jun; 4(2):467-76; discussion 476-7. PubMed ID: 2402614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of the expression of epidermal growth factor receptors in human transitional cell carcinoma.
    Messing EM
    Cancer Res; 1990 Apr; 50(8):2530-7. PubMed ID: 1690599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus-mediated gene therapy for bladder cancer: efficient gene delivery to normal and malignant human urothelial cells in vitro and ex vivo.
    Chester JD; Kennedy W; Hall GD; Selby PJ; Knowles MA
    Gene Ther; 2003 Jan; 10(2):172-9. PubMed ID: 12571646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-risk superficial bladder cancer: intravesical therapy for T1 G3 transitional cell carcinoma of the urinary bladder.
    Pham HT; Soloway MS
    Semin Urol Oncol; 1997 Aug; 15(3):147-53. PubMed ID: 9394909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy of bladder cancer using autologous dendritic cells pulsed with human lymphocyte antigen-A24-specific MAGE-3 peptide.
    Nishiyama T; Tachibana M; Horiguchi Y; Nakamura K; Ikeda Y; Takesako K; Murai M
    Clin Cancer Res; 2001 Jan; 7(1):23-31. PubMed ID: 11205913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.
    Lamm DL; Blumenstein BA; Crissman JD; Montie JE; Gottesman JE; Lowe BA; Sarosdy MF; Bohl RD; Grossman HB; Beck TM; Leimert JT; Crawford ED
    J Urol; 2000 Apr; 163(4):1124-9. PubMed ID: 10737480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies raised against cell membrane components of human bladder tumor tissue recognizing subpopulations in normal urothelium.
    Summerhayes IC; McIlhinney RA; Ponder BA; Shearer RJ; Pocock RD
    J Natl Cancer Inst; 1985 Dec; 75(6):1025-38. PubMed ID: 2415743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCG-induced interleukin-6 upregulation and BCG internalization in well and poorly differentiated human bladder cancer cell lines.
    Bevers RF; de Boer EC; Kurth KH; Schamhart DH
    Eur Cytokine Netw; 1998 Jun; 9(2):181-6. PubMed ID: 9681394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human bladder cancer associated antigens: evaluation of antigenicity in TCC tissues of different grades and in normal urothelium.
    Ben-Aïssa H; Paulie S; Gustafsson B; Håkansson L; Lagerkvist M; Gustafson H; Ahlstrand C; Perlmann P
    Anticancer Res; 1988; 8(3):443-9. PubMed ID: 3389746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence and progression of stage T1, grade 3 transitional cell carcinoma of the bladder following intravesical immunotherapy with bacillus Calmette-Guerin.
    Brake M; Loertzer H; Horsch R; Keller H
    J Urol; 2000 Jun; 163(6):1697-701. PubMed ID: 10799163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo retroviral mediated gene transfer into bladder urothelium results in preferential transduction of tumoral cells.
    Dumey N; Mongiat-Artus P; Devauchelle P; Lesourd A; Cotard JP; Le Duc A; Marty M; Cussenot O; Cohen-Haguenauer O
    Eur Urol; 2005 Feb; 47(2):257-63. PubMed ID: 15661423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravesical bacillus Calmette-Guerin therapy for stage T1 grade 3 transitional cell carcinoma of the bladder: recurrence, progression and survival in a study of 57 patients.
    Peyromaure M; Guerin F; Amsellem-Ouazana D; Saighi D; Debre B; Zerbib M
    J Urol; 2003 Jun; 169(6):2110-2. PubMed ID: 12771729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of vitamin D (calcitriol) on transitional cell carcinoma of the bladder in vitro and in vivo.
    Konety BR; Lavelle JP; Pirtskalaishvili G; Dhir R; Meyers SA; Nguyen TS; Hershberger P; Shurin MR; Johnson CS; Trump DL; Zeidel ML; Getzenberg RH
    J Urol; 2001 Jan; 165(1):253-8. PubMed ID: 11125420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.